HENDERSON, CO, August 1, 2018 – PRESS RELEASE – Nuka Enterprises announced today that former New Jersey Gov. James Florio will join the company’s advisory board and will be supporting Nuka’s expansion initiatives into New Jersey through his law firm, Florio Perrucci Steinhardt & Capelli, LLC. The deal adds significant political and intellectual capital to Nuka’s advisory board as the company brings its expertise, history of innovation, and market leadership to New Jersey. Nuka’s 1906 brand cannabis edibles have been recognized for their taste, fast onset time and use of plant medicines to deliver desired effects.
“The people of New Jersey have recognized and acknowledged the importance of cannabis legalization as a medicinal, social justice and economic issue, and that the time for responsible change has come,” said Gov. James Florio. “I am proud to be partnering with Nuka who have been recognized for their safe, innovative and progressive approach to the cannabis edibles market. I also believe in Peter Barsoom, Nuka’s founder and CEO, who is a New Jersey native and a thought leader in the industry, promoting responsible consumption of legal cannabis in a regulated market that protects the consumer.”
Gov. Florio and his law firm will work with Nuka’s leadership team in support of their New Jersey expansion initiatives. As the state moves rapidly toward adult use legalization and an expansion of medicinal programs, Governor Florio and Nuka will bring their insights, experience and resources to New Jersey legislators, organizations and businesses to ensure responsible development and implementation of new policies.
“It is an honor to be working with Gov. Florio, one of New Jersey’s most celebrated leaders, and to have his experience, community, and support and shared values with Nuka and 1906,” said Peter Barsoom, CEO of Nuka Enterprises. “This is an exciting time of economic growth in New Jersey, which has the potential to be totally transformative for cannabis legislation and regulation. New Jersey is the home of so many highly-regulated industries, including pharmaceutical and biotech, and robust research institutions. We’ve got incredible resources and models, and we have executive support across all branches of government–our governor and both leaders of the the legislative branch. This is our opportunity to get this right–to get social justice right, to get research right, to get the consumer experience right–and when we do, we will set best practices and standards for the entire world.”]]>